Symbol="BIOC"
AssetType="Common Stock"
Name="Biocept Inc"
Description="Biocept, Inc., an early stage molecular oncology diagnostic company, develops and markets proprietary circulating tumor cells and circulating tumor nucleic acid assays using a standard blood sample. The company is headquartered in San Diego, California."
CIK="1044378"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SERVICES-MEDICAL LABORATORIES"
Address="9955 MESA RIM ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1910200"
EBITDA="-35215000"
PERatio="None"
PEGRatio="-0.04"
BookValue="4.095"
DividendPerShare="0"
DividendYield="0"
EPS="-64.55"
RevenuePerShareTTM="11.52"
ProfitMargin="0"
OperatingMarginTTM="-5.61"
ReturnOnAssetsTTM="-0.543"
ReturnOnEquityTTM="-1.877"
RevenueTTM="6586000"
GrossProfitTTM="-2582000"
DilutedEPSTTM="-64.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.966"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.197"
PriceToBookRatio="0.372"
EVToRevenue="0.0893"
EVToEBITDA="-0.336"
Beta="0.817"
num_52WeekHigh="36"
num_52WeekLow="1.1"
num_50DayMovingAverage="2.758"
num_200DayMovingAverage="13.28"
SharesOutstanding="1469400"
DividendDate="2020-09-08"
ExDividendDate="None"
symbol="BIOC"
open="1.29"
high="1.35"
low="1.24"
price="1.29"
volume="141268.00"
latest_trading_day="2023-07-21"
previous_close="1.30"
change="-0.01"
change_percent="-0.7692%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="221313"
Change_recent_avg="-0.03"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-2.74"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="501"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0104.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
